MYGN (STOCKS)
Myriad Genetics Inc
$4.320000
-0.010000 (-0.23%)
Prev close: $4.330000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Samraat S Raha
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $408.02M
- Employees
- 2,700
- P/E (TTM)
- -1.00
- P/B (TTM)
- 1.21
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
2
Buy
9
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.09 | $-0.07 | -0.0202 | -28.94% |
|
Dec 2025 (Q4)
|
$0.04 | $-0.01 | +0.0549 | +368.46% |
|
Sep 2025 (Q3)
|
$0.00 | $-0.01 | +0.0080 | +100.00% |
|
Jun 2025 (Q2)
|
$0.05 | $-0.01 | +0.0595 | +626.32% |
Financial Statements
| Revenues | $829.00M |
| Benefits Costs and Expenses | $1.23B |
| Cost Of Revenue | $249.00M |
| Costs And Expenses | $1.23B |
| Gross Profit | $580.00M |
| Nonoperating Income/Loss | -$10.90M |
| Operating Expenses | $968.90M |
| Depreciation and Amortization | $51.80M |
| Research and Development | $106.40M |
| Other Operating Expenses | $837.40M |
| Operating Income/Loss | -$388.90M |
| Income/Loss From Continuing Operations After Tax | -$399.90M |
| Income/Loss From Continuing Operations Before Tax | -$399.80M |
| Income Tax Expense/Benefit | $100.00K |
| Net Income/Loss | -$399.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$399.90M |
| Net Income/Loss Available To Common Stockholders, Basic | -$399.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.29 |
| Diluted Earnings Per Share | -$4.29 |
| Basic Average Shares | 279,600,000 |
| Diluted Average Shares | 279,600,000 |
| Assets | $673.70M |
| Current Assets | $312.80M |
| Inventory | $27.90M |
| Other Current Assets | $284.90M |
| Noncurrent Assets | $360.90M |
| Fixed Assets | $111.50M |
| Intangible Assets | $145.70M |
| Other Non-current Assets | $103.70M |
| Liabilities | $336.30M |
| Current Liabilities | $130.20M |
| Accounts Payable | $32.60M |
| Wages | $39.80M |
| Other Current Liabilities | $57.80M |
| Noncurrent Liabilities | $206.10M |
| Long-term Debt | $120.30M |
| Other Non-current Liabilities | $85.80M |
| Equity | $337.40M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $337.40M |
| Liabilities And Equity | $673.70M |
| Net Cash Flow From Operating Activities | $2.40M |
| Net Cash Flow From Operating Activities, Continuing | $2.40M |
| Net Cash Flow From Investing Activities | -$25.60M |
| Net Cash Flow From Investing Activities, Continuing | -$25.60M |
| Net Cash Flow From Financing Activities | $47.60M |
| Net Cash Flow From Financing Activities, Continuing | $47.60M |
| Exchange Gains/Losses | $600.00K |
| Net Cash Flow | $25.00M |
| Net Cash Flow, Continuing | $24.40M |
| Comprehensive Income/Loss | -$399.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$398.60M |
| Other Comprehensive Income/Loss | -$68.60M |
| Other Comprehensive Income/Loss Attributable To Parent | $1.30M |